Erste Asset Management Gmb H Deciphera Pharmaceuticals, Inc. Transaction History

Erste Asset Management Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Nov 22, 2024	SELL	$6.87 - $11.11 $125,721 - $203,313	-18,300 Closed	0 $0
Q4 2021 Nov 22, 2024	BUY	$7.7 - $37.13 $140,910 - $679,479	18,300 New	18,300 $171 Million
Q3 2020 Nov 22, 2024	BUY	$43.8 - $58.16 $801,540 - $1.06 Million	18,300 New	18,300 $907 Million
Q1 2020 Nov 22, 2024	BUY	$33.63 - $69.4 $615,429 - $1.27 Million	18,300 New	18,300 $767 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.